DataMeds AI's Corexa Pharmacy tops $1M in monthly revenue

DataMeds AI, Inc. (NASDAQ: MEDS) reported that its Corexa Pharmacy division recorded preliminary, unaudited revenue of more than $1 million for September 2026, according to a company press release.

The figure represents an increase of more than 66% compared to revenue reported for July 2026. Corexa Pharmacy is a division of Corexa Health, a wholly owned subsidiary of DataMeds AI.

Gerald Commissiong, Interim Co-CEO of DataMeds AI, attributed the growth in part to the launch of Tollo Health's proprietary dietary supplements and medical foods, as well as organic growth from the company's retail customer base. Commissiong noted growth in both prescriptions filled and ancillary product sales.

The company also cited the launch of the Health Lives Here mobile application, which lists Corexa Pharmacy as a fulfillment option for telehealth prescriptions, and the acquisition of Helomics Corporation as factors it expects to influence future demand for oncology-based medications and nutritional support products.

DataMeds AI stated it is in the process of upgrading Corexa Pharmacy's physical location to serve as a model for its Health Lives Here initiative with NFL Alumni Health. The company said Corexa Pharmacy would be positioned as a reference model for other pharmacies within Corexa Health's network of more than 6,500 independent pharmacy locations.

The September revenue figures are preliminary, unaudited, and subject to change. DataMeds AI is headquartered in Tampa, Florida.

You May Also Be Interested In

• US Treasury: 'Authorizing Wind Down Activities...the Offloading of Cargo Involving Certain Persons or Vessels Blocked on October 21, 2026'
• Uniserve Provides Vancouver Data Centre Update and Advances Canadian Digital Infrastructure Strategy
• Blackstone and Apollo in talks for NFL private equity approval - Bloomberg